HBSP (USA)
-
Red Star Furniture Group Co. LTD. (Spanish Version)
Palepu, Krishna G.; Nueno, PedroCase HBS-114S14EntrepreneurshipFundada en 1986, el Estrella Roja se había convertido en la principal tienda de departamento en China para los productos de mobiliario y equipamiento del hogar (baño, lámparas, textiles complementos, etc.). El modelo de negocio de Red Star era proporcionar un espacio adecuado para los vendedores (que alquilan el espacio) en buen centro comercial, un bien diseñado y equipado (estacionamiento, transporte, servicios) ubicados en zonas clave de creci...Starting at €8.20
-
Red Star Furniture Group Co. LTD.
Palepu, Krishna G.; Nueno, PedroCase HBS-114053-EEntrepreneurshipFounded in 1986, Red Star had become the leading department store in China for furniture and home equipment products (bathroom, lamps, textiles complements, etc.). The business model of Red Star was to provide adequate space for vendors (that rented the space) in good shopping mall facilities, well designed and equipped (parking, transportation, services) located in key developing zones of Chinese growing cities. In the first 27 years, Red Star h...Starting at €8.20
-
GlaxoSmithKline in China (A)
Quelch, John A.; Rodriguez, MargaretCase HBS-514049-EMarketingFour GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to local customs while still observing local laws.Starting at €8.20
-
GlaxoSmithKline in China (B)
Quelch, John A.; Rodriguez, MargaretCase HBS-514050-EMarketingIn 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later, GSK's CEO, Andrew Witty, called the allegations "shameful" and said the company would use the opportunity to "make changes."Starting at €5.74
-
GlaxoSmithKline in China (C)
Quelch, John A.; Rodriguez, MargaretCase HBS-514092-EMarketingThis case is a follow up to GlaxoSmithKline (A), 514049 and GlaxoSmithKline (B), 514050.Starting at €5.74